Medtronic plc (MDT), headquartered in Dublin, Ireland, is the world’s largest medical device company. With a market cap of $108.06 billion, the company specializes in developing, manufacturing, and selling device-based medical therapies globally. It focuses on cardiac and vascular care, diabetes management, restorative therapies, and minimally invasive surgical procedures. Medtronic’s innovative technologies aim to alleviate pain, restore health, and extend life, benefiting healthcare systems, physicians, clinicians, and patients worldwide.
Medtronic has underperformed the broader market over the last year. The stock has declined 6.6% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 27.1%. In 2024, MDT’s stock is down 1.2%, compared to SPX's 10.4% gains on a YTD basis.
